Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo- and active-controlled study of ASKC200 topical solution for pain in knee osteoarthritis
CTR20253713Phase 2Active
- Sponsor
- Aosaikang Biotherapeutics
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CGS-200-5 in knee osteoarthritis (OA), sponsored by Aosaikang Biotherapeutics. Started Sep 2025; status: active.
02
Drugs
CGS-200-5
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20253713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253713.